GNCA
Barclays’s Genocea Biosciences, Inc. GNCA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3
| Closed | – | – | 5029 |
|
|
2022
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 5162 |
|
|
2021
Q2 | – | Sell |
-1,763
| Closed | -$5K | – | 4336 |
|
|
2021
Q1 | $5K | Buy |
+1,763
| New | +$5K | ﹤0.01% | 3764 |
|
|
2020
Q3 | – | Sell |
-56
| Closed | – | – | 4110 |
|
|
2020
Q2 | $0 | Buy |
+56
| New | – | ﹤0.01% | 4123 |
|
|
2019
Q3 | – | Sell |
-14,324
| Closed | -$58K | – | 4683 |
|
|
2019
Q2 | $58K | Buy |
+14,324
| New | +$58K | ﹤0.01% | 3798 |
|
|
2018
Q3 | – | Sell |
-4,344
| Closed | -$4K | – | 4627 |
|
|
2018
Q2 | $4K | Sell |
4,344
-12,725
| -75% | -$11.7K | ﹤0.01% | 4045 |
|
|
2018
Q1 | $18K | Buy |
17,069
+9,545
| +127% | +$10.1K | ﹤0.01% | 3865 |
|
|
2017
Q4 | $8K | Buy |
7,524
+6,861
| +1,035% | +$7.3K | ﹤0.01% | 3856 |
|
|
2017
Q3 | $1K | Sell |
663
-6,703
| -91% | -$10.1K | ﹤0.01% | 3982 |
|
|
2017
Q2 | $38K | Sell |
7,366
-9,634
| -57% | -$49.7K | ﹤0.01% | 3102 |
|
|
2017
Q1 | $104K | Buy |
+17,000
| New | +$104K | ﹤0.01% | 2818 |
|
|
2016
Q3 | – | Sell |
-2,109
| Closed | -$9K | – | 4146 |
|
|
2016
Q2 | $9K | Buy |
+2,109
| New | +$9K | ﹤0.01% | 3025 |
|
|
2015
Q4 | – | Sell |
-113
| Closed | -$1K | – | 4014 |
|
|
2015
Q3 | $1K | Sell |
113
-241
| -68% | -$2.13K | ﹤0.01% | 3849 |
|
|
2015
Q2 | $4K | Buy |
354
+219
| +162% | +$2.48K | ﹤0.01% | 3743 |
|
|
2015
Q1 | $1K | Sell |
135
-182
| -57% | -$1.35K | ﹤0.01% | 4019 |
|
|
2014
Q4 | $2K | Buy |
317
+190
| +150% | +$1.2K | ﹤0.01% | 4042 |
|
|
2014
Q3 | $1K | Buy |
127
+64
| +102% | +$504 | ﹤0.01% | 4264 |
|
|
2014
Q2 | $1K | Sell |
63
-43
| -41% | -$683 | ﹤0.01% | 4249 |
|
|
2014
Q1 | $2K | Buy |
+106
| New | +$2K | ﹤0.01% | 4165 |
|